Clinical Trials
4 trialsNCT03098030 2020-12-09
Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer
United Therapeutics
Phase 2/3 Completed
NCT03239171 2019-01-25
Bioinformation Therapy for Lung Cancer
Fuda Cancer Hospital, Guangzhou
Phase 2/3 Completed
NCT00930891 2016-03-10
CPC
Intergroupe Francophone de Cancerologie Thoracique
Phase 2/3 Completed
NCT00290953 2008-12-23
SESAME
Sanofi
Phase 2/3 Completed